These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24670212)

  • 1. Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia.
    Limosin F
    BMC Psychiatry; 2014 Mar; 14():88. PubMed ID: 24670212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model.
    Read J; Perry BD; Moskowitz A; Connolly J
    Psychiatry; 2001; 64(4):319-45. PubMed ID: 11822210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.
    Guest PC; Martins-de-Souza D; Vanattou-Saifoudine N; Harris LW; Bahn S
    Int Rev Neurobiol; 2011; 101():145-68. PubMed ID: 22050851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress axis dysfunction in schizophrenia.
    Yeap S; Thakore JH
    Eur Psychiatry; 2005 Oct; 20 Suppl 3():S307-12. PubMed ID: 16459241
    [No Abstract]   [Full Text] [Related]  

  • 5. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia.
    Walker E; Mittal V; Tessner K
    Annu Rev Clin Psychol; 2008; 4():189-216. PubMed ID: 18370616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia: a unique translational opportunity in behavioral neuroendocrinology.
    Koenig JI
    Horm Behav; 2006 Nov; 50(4):602-11. PubMed ID: 16870188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.
    Taylor SF; Grove TB; Ellingrod VL; Tso IF
    Schizophr Bull; 2019 Oct; 45(6):1170-1183. PubMed ID: 31150555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.
    Thompson JL; Pogue-Geile MF; Grace AA
    Schizophr Bull; 2004; 30(4):875-900. PubMed ID: 15954196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia: a neural diathesis-stress model.
    Walker EF; Diforio D
    Psychol Rev; 1997 Oct; 104(4):667-85. PubMed ID: 9337628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, and the neurodevelopmental course of schizophrenia.
    Walker E
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():363s-369s. PubMed ID: 23573606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stress and psychosis].
    Halsband SA
    Vertex; 2002; 13 Suppl 1():12-6. PubMed ID: 12122422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction].
    Mello MF; Faria AA; Mello AF; Carpenter LL; Tyrka AR; Price LH
    Braz J Psychiatry; 2009 Oct; 31 Suppl 2(0 2):S41-8. PubMed ID: 19967199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis.
    Mittal VA; Orr JM; Pelletier A; Dean DJ; Smith A; Lunsford-Avery J
    Psychiatry Res; 2013 Apr; 206(2-3):315-7. PubMed ID: 23332683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC
    Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls.
    Brunelin J; d'Amato T; van Os J; Cochet A; Suaud-Chagny MF; Saoud M
    Schizophr Res; 2008 Mar; 100(1-3):206-11. PubMed ID: 18155448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
    Nordholm D; Rostrup E; Mondelli V; Randers L; Nielsen MØ; Wulff S; Nørbak-Emig H; Broberg BV; Krakauer K; Dazzan P; Zunszain PA; Nordentoft M; Glenthøj B
    Psychoneuroendocrinology; 2018 Jun; 92():72-80. PubMed ID: 29635174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment.
    Altamura AC; Boin F; Maes M
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):1-4. PubMed ID: 10647089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
    Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
    Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HPA axis response to social stress in schizophrenia by childhood trauma.
    Lange C; Huber CG; Fröhlich D; Borgwardt S; Lang UE; Walter M
    Psychoneuroendocrinology; 2017 Aug; 82():126-132. PubMed ID: 28549268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.